CRLX101: Phase II data

Top-line data from an open-label, U.S. and South Korean Phase II trial in 115 patients with metastatic RCC who progressed

Read the full 203 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE